发明名称 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease.
摘要 This invention concerns a bicyclic compound of Formula (I), wherein: G is N, CH or C(CN); ring X is a 5- or 6-membered fused heteroaryl ring which contains 1, 2, or 3 heteroatoms selected from oxygen, sulphur and nitrogen; m is 0-2; R<1 >is a group such as hydroxy, halo, trifluoromethyl, cyano, mercapto, nitro, amino, carboxy and carbamoyl; each of R<2 >and R<3 >is hydrogen, halo, C1-6alkyl, C2-6alkenyl or C2-6 alkynyl; R<4 >is a group such as hydrogen, hydroxy, C1-6alkyl, C1-6alkoxy, amino and N-C1-6alkylamino; R<5 >is a group such as hydrogen, halo, trifluoromethyl, cyano, nitro, amino and hydroxy, and q is 0-4; or a pharmaceutically acceptable salt or an in vivo cleavable ester thereof; processes for its preparation, a pharmaceutical composition containing it and its use in the treatment of diseases or medical conditions mediated by cytokines.
申请公布号 ZA200107501(B) 申请公布日期 2003.02.26
申请号 ZA20010007501 申请日期 2001.09.11
申请人 ASTRAZENECA AB. 发明人 JOHN GRAHAM CUMMING
分类号 C07D473/34;A61K31/519;A61K31/52;A61P1/02;A61P1/04;A61P1/16;A61P7/02;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P19/00;A61P19/02;A61P19/06;A61P19/10;A61P21/00;A61P25/28;A61P29/00;A61P31/04;A61P31/10;A61P31/12;A61P31/18;A61P35/00;A61P35/04;A61P37/08;A61P43/00;C07D471/04;C07D475/06;C07D495/04;C07D513/04 主分类号 C07D473/34
代理机构 代理人
主权项
地址
您可能感兴趣的专利